Skip to main content
. 2013 Oct 29;2013:849042. doi: 10.1155/2013/849042

Figure 1.

Figure 1

Cumulative incidence of antiretroviral therapy (ART) initiation, death before ART initiation, and loss to followup since ART eligibility (a), ART initiation by CD4+ lymphocyte count (b), mortality by CD4 overall and stratified by CD4+ lymphocyte count (c), and loss to followup by CD4+ lymphocyte count (d).